Breaking News
Get 50% Off 0
Unlock Premium Data: Up to 50% Off InvestingPro CLAIM SALE
Close

D.Western Therapeutics Institute Inc (4576)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
92.0 +1.0    +1.10%
03:30:00 - Delayed Data. Currency in JPY ( Disclaimer )
  • Volume: 481,000
  • Bid/Ask: 93.0 / 94.0
  • Day's Range: 91.0 - 95.0
Type:  Equity
Market:  Japan
ISIN:  JP3548740004 
D.Western Therapeutics Institute 92.0 +1.0 +1.10%

4576 Balance Sheet

 
Assess the latest D.Western Therapeutics Institute Inc balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced 4576 Annual Report data, financial summaries and charts are available for D.Western Therapeutics Institute Inc investors with their own InvestingPro account.
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 1886 2137 2348 2540
Cash and Short Term Investments 1387 1867 2038 2235
Cash - - - -
Cash & Equivalents 1387 1867 2038 2235
Short Term Investments - - - -
Total Receivables, Net 152 117 170 102
Accounts Receivables - Trade, Net 152 117 170 102
Total Inventory 84 87 85 140
Prepaid Expenses - - - -
Other Current Assets, Total 263 66 55 63
Total Assets 2117 2373 2626 2820
Property/Plant/Equipment, Total - Net 16 10 17 11
Property/Plant/Equipment, Total - Gross - 111.39 - -
Accumulated Depreciation, Total - -101.38 - -
Goodwill, Net - - - -
Intangibles, Net 75 86 95 103
Long Term Investments 138 138 164 164
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 2 2 2 2
Other Assets, Total 195 36 -30 101
Total Current Liabilities 154 194 158 207
Accounts Payable - 161.36 - -
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 14 9 34 60
Other Current liabilities, Total 140 185 124 147
Total Liabilities 1159 1094 975 1001
Total Long Term Debt 979 875 791 768
Long Term Debt 979 875 791 768
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - 4 8
Other Liabilities, Total 26 -254 -198 -186
Total Equity 958 1279 1651 1819
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 831 831 831 815
Additional Paid-In Capital 2889 2889 2889 2873
Retained Earnings (Accumulated Deficit) -2763 -2442 -2073 -1877
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 1 1 4 8
Total Liabilities & Shareholders' Equity 2117 2373 2626 2820
Total Common Shares Outstanding 32.13 32.13 32.13 31.96
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4576 Price Commentary

Write your thoughts about D.Western Therapeutics Institute Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email